A Study of Anti-VEGF Monoclonal Antibody hPV19 in Patients With Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
Clinical Trials Related to 5-Fluorouracil
Related studies linked through entity extraction aliases.
Cetuximab Plus FOLFOXIRI vs Cetuximab Plus FOLFOX For CRCLM
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Post Marketing Surveillance Study for ONIVYDE® in South Korea
- Status
- COMPLETED
- Phase
- N/A
Study of Atezolizumab + FLOT vs. FLOT Alone in Patients With GC/GEJ and High Immune Responsiveness
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
CAPTEM or FOLFIRI as SEcond-line Therapy in NEuroendocrine CArcinomas
- Status
- TERMINATED
- Phase
- PHASE2
QUILT-3.067: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With TNBC Who Have Progressed on or After Standard-of-care Therapy.
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Intralesional 5-Fluorouracil (5FU), Topical Calcipotriene Treatment for SCC
- Status
- RECRUITING
- Phase
- PHASE1
mFOLFOX6 Chemotherapy With Apatinib as Postoperative Treatment in Stage IIIB or IIIC Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Pembrolizumab Plus Epacadostat, Pembrolizumab Monotherapy, and the EXTREME Regimen in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (KEYNOTE-669/ECHO-304)
- Status
- COMPLETED
- Phase
- PHASE3
Nivolumab Plus Epacadostat in Combination With Chemotherapy Versus the EXTREME Regimen in Squamous Cell Carcinoma of the Head and Neck (CheckMate 9NA/ECHO-310)
- Status
- WITHDRAWN
- Phase
- PHASE3
A Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Assessment of Metabolic & Path Response w/ RCT & ImT Before Surgery in Locally Advanced Esoph and Gastro-esoph Jction CA
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Chemoradiotherapy Versus Esophagectomy After Endoscopic Resection for Superficial Esophageal Squamous Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Oxaliplatin in PIPAC for Nonresectable Peritoneal Metastases of Digestive Cancers
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Pilot Study of FOLFIRINOX in Combination With Neoadjuvant Radiation for Gastric and GE Junction Cancers
- Status
- COMPLETED
- Phase
- PHASE1
First Line mFOLFOXIRI + PANITUMUMAB vs mFOLFOX + PANITUMUMAB IN RAS AND BRAF WT METASTATIC COLORECTAL CANCER PATIENTS
- Status
- COMPLETED
- Phase
- PHASE3
Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585)
- Status
- COMPLETED
- Phase
- PHASE3
The Role of 5-Fluorouracil in Post-Operative Scar Formation Following Direct Brow Ptosis Repair
- Status
- UNKNOWN
- Phase
- PHASE3
Clinical Study of Apatinib and 5-Fu Combination Regimen to Treat Advanced Colorectal Cancer Patients
- Status
- UNKNOWN
- Phase
- PHASE2
CMAB009 Combined With FOLFIRI First-line Treatment in Patients With RAS/BRAF Wild-type, Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE3